Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al

Jos Runhaar; Rianne M. Rozendaal; Marienke Van Middelkoop; Hans J.W. Bijlsma; Michael Doherty; Krysia S. Dziedzic; L. Stefan Lohmander; Timothy McAlindon; Weiya Zhang; Sita Bierma Zeinstra

doi:10.1136/annrheumdis-2017-212276

Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al

Jos Runhaar, Rianne M. Rozendaal, Marienke Van Middelkoop, Hans J.W. Bijlsma, Michael Doherty, Krysia S. Dziedzic, L. Stefan Lohmander, Timothy McAlindon, Weiya Zhang, Sita Bierma Zeinstra

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e40
Journal	Annals of the Rheumatic Diseases
Volume	77
Issue number	7
DOIs	https://doi.org/10.1136/annrheumdis-2017-212276
Publication status	Published - 2018 Jul

Subject classification (UKÄ)

Clinical Medicine

Access to Document

10.1136/annrheumdis-2017-212276

Cite this

Runhaar, J., Rozendaal, R. M., Van Middelkoop, M., Bijlsma, H. J. W., Doherty, M., Dziedzic, K. S., Stefan Lohmander, L., McAlindon, T., Zhang, W., & Zeinstra, S. B. (2018). Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al. Annals of the Rheumatic Diseases, 77(7), Article e40. https://doi.org/10.1136/annrheumdis-2017-212276

@article{3b7d54583a324476bc7bcfda6e5eb213,

title = "Response to: {\textquoteleft}Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms{\textquoteright} by reginster et al",

author = "Jos Runhaar and Rozendaal, {Rianne M.} and {Van Middelkoop}, Marienke and Bijlsma, {Hans J.W.} and Michael Doherty and Dziedzic, {Krysia S.} and {Stefan Lohmander}, L. and Timothy McAlindon and Weiya Zhang and Zeinstra, {Sita Bierma}",

year = "2018",

month = jul,

doi = "10.1136/annrheumdis-2017-212276",

language = "English",

volume = "77",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "7",

}

Runhaar, J, Rozendaal, RM, Van Middelkoop, M, Bijlsma, HJW, Doherty, M, Dziedzic, KS, Stefan Lohmander, L, McAlindon, T, Zhang, W & Zeinstra, SB 2018, 'Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al', Annals of the Rheumatic Diseases, vol. 77, no. 7, e40. https://doi.org/10.1136/annrheumdis-2017-212276

TY - JOUR

T1 - Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al

AU - Runhaar, Jos

AU - Rozendaal, Rianne M.

AU - Van Middelkoop, Marienke

AU - Bijlsma, Hans J.W.

AU - Doherty, Michael

AU - Dziedzic, Krysia S.

AU - Stefan Lohmander, L.

AU - McAlindon, Timothy

AU - Zhang, Weiya

AU - Zeinstra, Sita Bierma

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85055584810&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2017-212276

DO - 10.1136/annrheumdis-2017-212276

M3 - Letter

C2 - 28916715

AN - SCOPUS:85055584810

SN - 0003-4967

VL - 77

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 7

M1 - e40

ER -

Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al

Subject classification (UKÄ)

Access to Document

Other files and links

Cite this